Atrial Fibrillation Trial, Recruiting NCT07611084 Sponsor: Jiangsu Taizhou People's Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07611084
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be a permanent resident with a local household registration in a rural area of China.
  • You must be between 65 and 80 years old.
  • You must have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed either by a heart tracing test (ECG) or by an official diagnosis letter from a specialist.
  • You must be willing to take part in screening for heart failure.
  • You must be able to understand what the study involves and sign a consent form agreeing to take part.

Who may not be able to join:

  • People who are not expected to live longer than 3 months may not be eligible.
  • People with severely reduced kidney function or who are currently receiving dialysis treatment may not be eligible.
  • People whose heart problems are caused by certain treatable conditions — such as an overactive thyroid, severe anaemia, or an uncorrected heart defect present from birth — may not be eligible.
  • People who have been told they need a pacemaker but have not yet had one fitted may not be eligible.
  • People who have a chronic lung disease (COPD) that has led to a serious type of breathing failure (confirm with trial site) may not be eligible.
  • People with mental health conditions may not be eligible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615996000626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jiangsu Taizhou People's Hospital
Registry
ClinicalTrials.gov
Start date
14 March 2026
Est. completion
31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Composite endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov